Elevated Sirtuin 1 Levels in Patients with Chronic Kidney Disease, Including on Peritoneal Dialysis: Associations...

Area of Science:

• Nephrology
• Cardiology
• Biochemistry

Background:

• Sirtuin 1 (SIRT1) is linked to oxidative stress, inflammation, and fibrosis, key factors in chronic kidney disease (CKD) and its cardiovascular complications.
• Elevated serum SIRT1 and its role in peritoneal fibrosis, a cause of peritoneal dialysis failure, are previously noted.

Purpose of the Study:

• To evaluate serum SIRT1 levels in patients undergoing continuous ambulatory peritoneal dialysis (CAPD), conservatively treated CKD patients (CT), and healthy controls.
• To explore the relationship between serum SIRT1 levels and clinical factors in CKD patients.

Main Methods:

• Serum SIRT1 levels were measured using ELISA in 165 participants (CAPD, CT, and controls).
• Clinical factors including age, sex, dialysis adequacy, residual renal function, comorbidities, and pharmacotherapy were analyzed.
• Multivariate analysis identified independent predictors of SIRT1.

Main Results:

• Serum SIRT1 concentrations were markedly elevated in CAPD patients compared to CT patients and healthy controls.
• In CAPD patients, SIRT1 levels correlated with impaired left ventricular relaxation but were not influenced by age, sex, dialysis adequacy, residual renal function, or comorbidities.
• Phosphate and cholesterol were identified as independent predictors of serum SIRT1 levels.

Conclusions:

• Serum SIRT1 levels may reflect complex pathophysiological processes in CKD patients, including those on peritoneal dialysis.
• Elevated SIRT1 could indicate compensatory responses to renal dysfunction and cardiovascular stress.
• Further research in larger, homogeneous groups is needed to clarify SIRT1's role in peritoneal fibrosis and its potential as a biomarker.